Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1

BACKGROUND: Doublecortin-like kinase 1 (DCLK1) is emerging as a tumor specific stem cell marker in colorectal and pancreatic cancer. Previous in vitro and in vivo studies have demonstrated the therapeutic effects of inhibiting DCLK1 with small interfering RNA (siRNA) as well as genetically targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Weygant, Nathaniel, Qu, Dongfeng, Berry, William L, May, Randal, Chandrakesan, Parthasarathy, Owen, Daniel B, Sureban, Sripathi M, Ali, Naushad, Janknecht, Ralf, Houchen, Courtney W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030036/
https://www.ncbi.nlm.nih.gov/pubmed/24885928
http://dx.doi.org/10.1186/1476-4598-13-103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030036/
https://www.ncbi.nlm.nih.gov/pubmed/24885928
http://dx.doi.org/10.1186/1476-4598-13-103

Ejemplares similares